<html><body><div style="width:400px;"><div class="tracker" data-tracker-id="twitter_1540096038584844292"><blockquote class="twitter-tweet"><p lang="en" dir="ltr">Congrats to our partner <a href="https://twitter.com/uniQure_NV?ref_src=twsrc%5Etfw">@uniQure_NV</a> on encouraging safety &amp; biomarker data from 10 patients enrolled in their Phase I/II clinical trial of AMT-130 for <a href="https://twitter.com/hashtag/HuntingtonsDisease?src=hash&amp;ref_src=twsrc%5Etfw">#HuntingtonsDisease</a>. Learn how <a href="https://twitter.com/hashtag/ClearPoint?src=hash&amp;ref_src=twsrc%5Etfw">#ClearPoint</a> supports uniQureâ€™s trial sites: <a href="https://t.co/7rFUCzgTJZ">https://t.co/7rFUCzgTJZ</a> <a href="https://t.co/xMmmZSn7g4">https://t.co/xMmmZSn7g4</a></p>&mdash; ClearPointNeuro (@ClearPointNeuro) <a href="https://twitter.com/ClearPointNeuro/status/1540048326938066944?ref_src=twsrc%5Etfw">June 23, 2022</a></blockquote>

</div></div></body><script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></html>